Every now and then an entrepreneur describes the current state of technology in a way that captures the marketplace in one impactful comment. That's what happened when a professor of genetics told the MIT Technology Review that an organization must be willing to spend money to get good data. "It takes a lot of labor and capital to get ... information in a form that is useful."
Against this norm came a company called 23andMe which offered a genetic analysis for just $199. Consumers grabbed the opportunity with both hands. The company has seen a phenomenal rise since, because anyone can order a kit by mail, provide a saliva sample, mail it back, and in a relatively short time receive an impressive genetic analysis. By that I mean a review of 650,000 genetic markers. The review allows scientists to detect common versions of each of the 20,000 genes a human being possesses.